HUYABIO is the leader in accelerating the global development of novel biopharmaceutical product opportunities originating in China enabling faster, more cost-effective and lower-risk drug development in the global markets. Through extensive collaboration with biopharmaceutical, academic and commercial organizations, it has built the largest China-sourced compound portfolio covering all therapeutic areas. With offices in the US, Japan, South Korea, Canada, Ireland and eight strategic locations across China, the Company has become a partner of choice to accelerate product development and maximize value globally.
View Top Employees from HUYABIO InternationalWebsite | http://www.huyabio.com |
Revenue | $16 million |
Funding | $350000 |
Employees | 123 (114 on RocketReach) |
Founded | 2004 |
Address | 12531 High Bluff Dr, San Diego, California 92130, US |
Phone | (858) 798-8800 |
Fax | (858) 798-8888 |
Technologies |
JavaScript,
HTML,
PHP
+17 more
(view full list)
|
Category | Biotechnology, Pharmaceutical Manufacturing, Pharmaceutical Development, Pharmaceuticals, Science and Engineering, Innovative drug in-licensing and out-licensing, Healthcare, Health Care, Pharmaceutical |
Web Rank | 10 Million |
Keywords | huya bioscience, huya pharma, shun lu shanghai chest hospital, 苏州苏健生物医药科技有限公司, biotech investment companies san diego |
Competitors | Affectis Pharmaceuticals, Aptahem, CANbridge Pharmaceuticals Inc., Debiopharm, XORTX Therapeutics Inc. |
SIC | 87, 873 |
NAICS | 541714, 54, 541, 54171, 5417 |
Looking for a particular HUYABIO International employee's phone or email?
The HUYABIO International annual revenue was $16 million in 2023.
William Davis is the Executive Vice President, Commercial Operations of HUYABIO International.
114 people are employed at HUYABIO International.
HUYABIO International is based in San Diego, California.
The NAICS codes for HUYABIO International are [541714, 54, 541, 54171, 5417].
The SIC codes for HUYABIO International are [87, 873].